MiMedx Group Inc MDXG
News
MIMEDX Announces Third Quarter 2026 Operating & Financial Results
MIMEDX Announces $25 Million Patent License Agreement
MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026
MiMedx Gets Favorable Court Ruling in FDA Treatment-Classification Dispute
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter
MIMEDX to Participate in Upcoming Investor Conferences
MiMedx Eliminates COO Role Amid Cost-Savings Push

